G754-0461 Screening compound: 8-{[(5-methyl-2-phenyl-1,3-oxazol-4-yl)methyl]sulfanyl}-9-[(oxolan-2-yl)methyl]-6,9-dihydro-1H-purin-6-one

G754-0461 Screening compound: 8-{[(5-methyl-2-phenyl-1,3-oxazol-4-yl)methyl]sulfanyl}-9-[(oxolan-2-yl)methyl]-6,9-dihydro-1H-purin-6-one
G754-0461 Screening compound: 8-{[(5-methyl-2-phenyl-1,3-oxazol-4-yl)methyl]sulfanyl}-9-[(oxolan-2-yl)methyl]-6,9-dihydro-1H-purin-6-one alternative view

Chemical Structure Depiction of ChemDiv screening compound G754-0461
8-{[(5-methyl-2-phenyl-1,3-oxazol-4-yl)methyl]sulfanyl}-9-[(oxolan-2-yl)methyl]-6,9-dihydro-1H-purin-6-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G754-0461

Molecular Formula

C21H21N5O3S (C21 H21 N5 O3 S)

Compound Name

8-{[(5-methyl-2-phenyl-1,3-oxazol-4-yl)methyl]sulfanyl}-9-[(oxolan-2-yl)methyl]-6,9-dihydro-1H-purin-6-one

IUPAC name

8-{[(5-methyl-2-phenyl-13-oxazol-4-yl)methyl]sulfanyl}-9-[(oxolan-2-yl)methyl]-69-dihydro-1H-purin-6-one

SMILES

Cc1c(CSc(n2CC3OCCC3)nc3c2N=CNC3=O)nc(-c2ccccc2)o1

InChI

InChI=1S/C21H21N5O3S/c1-13-16(24-20(29-13)14-6-3-2-4-7-14)11-30-21-25-17-18(22-12-23-19(17)27)26(21)10-15-8-5-9-28-15/h2-4,6-7,12,15H,5,8-11H2,1H3,(H,22,23,27)/t15-/m1/s1

InChI Key

MREZSQTUJUYEPW-OAHLLOKOSA-N

MDL Number (MFCD)

MFCD27155773

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

423.5

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.441

Distribution Coefficient, logD

2.441

Water Solubility, LogSw

-2.63

Polar Surface Area

74.207

Acid Dissociation Constant (pKa)

10.27

Base Dissociation Constant (pKb)

3.28

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

33.30

G754-0461 in Drug Discovery

Included in Screening Libraries

KRAS-Targeted Library (16000 compounds)

Nucleoside Mimetics Library (2197 compounds)

Purine Based Nucleoside Mimetics Library (1131 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Antiviral
  • Infections
  • Cancer
  • Immune system
Targets:
  • Kinases
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with G754-0461 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G754-0461?
Check Price and Availability of G754-0461, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G754-0461 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G754-0461
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G754-0461
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G754-0461 available by request